Pramoxine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML Topical Lotion [Calaclear] — RxCUI 1248193
RxNorm drug concept · Semantic branded drug
RxCUI 1248193
Semantic branded drug · SBD
● Current RxNorm concept 3 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1248193
Official namePramoxine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML Topical Lotion [Calaclear]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asCalaclear (pramoxine hydrochloride 1 % / zinc acetate 0.1 % ) Topical Lotion; CALACLEAR 1 % / 0.1 % Topical Lotion
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Pramoxine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It gives short-term relief from pain and itching from minor problems like sunburn, minor burns, insect bites, and poison ivy rashes. Some products are made for specific uses, like...
- That depends on the product. Many say not more than 3 to 4 times daily, and some allow up to 5 times daily. Check your label and follow it closely.
- No. It is for external use only. If it gets in your eyes, rinse thoroughly with water.
- Can I use it inside the vagina or near my eyes?
🕸️ Concept Web — How Pramoxine hydrochloride 10 MG/ML / zinc acetate... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Pramoxine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML Topical Lotion [Calaclear]
RxCUI 1248193 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Pramoxine
34347IN -
Zinc acetate
58295IN -
Pramoxine / zinc acetate
1007357MIN -
Pramoxine hydrochloride
57555PIN
-
Pramoxine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Calaclear
215810BN
-
Calaclear
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Pramoxine / zinc acetate Topical Lotion
377921SCDF -
Pramoxine hydrochloride / zinc acetate Topical Lotion
2647745SCDFP -
Pramoxine / zinc acetate Topical Product
1165737SCDG -
Pramoxine hydrochloride / zinc acetate Topical Product
2659802SCDGP -
Pramoxine / zinc acetate Topical Lotion [Calaclear]
365716SBDF -
Pramoxine hydrochloride / zinc acetate Topical Lotion [Calaclear]
2654786SBDFP -
Calaclear Topical Product
1170868SBDG -
Topical Lotion
316983DF - +1 more in this family
-
Pramoxine / zinc acetate Topical Lotion
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Pramoxine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML Topical Lotion
1234546SCD -
Pramoxine hydrochloride 10 MG/ML
828361SCDC -
Zinc acetate 1 MG/ML
340184SCDC -
Pramoxine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML [Calaclear]
1248192SBDC
-
Pramoxine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML Topical Lotion
Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Pramoxine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML Topical Lotion
SCD · 1234546 -
Pramoxine hydrochloride 10 MG/ML
SCDC · 828361 -
Zinc acetate 1 MG/ML
SCDC · 340184 -
Pramoxine / zinc acetate Topical Lotion
SCDF · 377921 -
Pramoxine hydrochloride / zinc acetate Topical Lotion
SCDFP · 2647745 -
Pramoxine / zinc acetate Topical Product
SCDG · 1165737 -
Pramoxine hydrochloride / zinc acetate Topical Product
SCDGP · 2659802
Brand-Name Concepts
-
Pramoxine hydrochloride 10 MG/ML / zinc acetate 1 MG/ML [Calaclear]
SBDC · 1248192 -
Pramoxine / zinc acetate Topical Lotion [Calaclear]
SBDF · 365716 -
Pramoxine hydrochloride / zinc acetate Topical Lotion [Calaclear]
SBDFP · 2654786 -
Calaclear Topical Product
SBDG · 1170868 -
Calaclear
BN · 215810
📦 FDA Products & Package NDCs
3 products · 3 package NDCs
3 package NDCs map to RxCUI 1248193 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00395-0400-96 | 177 mL in 1 BOTTLE, PLASTIC (0395-0400-96) | Humco Calaclear | Humco Holding Group, Inc. | 1998-03-25 |
| 49035-0402-96 | 177 mL in 1 BOTTLE, PLASTIC (49035-402-96) | Calaclear | Wal-Mart Stores, Inc. | 2018-01-03 |
| 82645-0923-96 | 177 mL in 1 BOTTLE, PLASTIC (82645-923-96) | Calaclear | Pharma Nobis, LLC | 1998-03-25 |
Observed labelers:
Humco Holding Group, Inc. (1) ·
Pharma Nobis, LLC (1) ·
Wal-Mart Stores, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.